Multiple Sclerosis
Pathologie
Gilenya®
Patient Resources
westvlaams
We hope we put a smile on your face!
Have a brilliant day,
Virginie and Luca
Twitter Linkedin Facebook Pinterest Google plusliegeois
We hope we put a smile on your face!
Have a brilliant day,
Virginie and Luca
Twitter Linkedin Facebook Pinterest Google plusKymriah® Info
Indication
Alpelisib (Piqray ® ) is indicated in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor (HR)- positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or...
Twitter Linkedin Facebook Pinterest Google plusEfficacy
SOLAR-1:
Pivotal randomized, double-blind, placebo-controlled, multicenter phase 3 trial in HR+/HER2-aBC 1 . A total of 572 patients were enrolled in the trial, including 341 patients with a PIK3CA mutation 1...
Twitter Linkedin Facebook Pinterest Google plus
×